TipRanks
Advertisement
Advertisement
PolyPid reports Q2 EPS (35c), consensus (38c)
PremiumThe FlyPolyPid reports Q2 EPS (35c), consensus (38c)
2M ago
PolyPid Earnings Call: Priority Review, Big Azurity Deal
Premium
Company Announcements
PolyPid Earnings Call: Priority Review, Big Azurity Deal
2M ago
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline
Premium
Company Announcements
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline
2M ago
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
PremiumCompany AnnouncementsPolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
3M ago
PolyPid price target lowered to $12 from $13 at Craig-Hallum
Premium
The Fly
PolyPid price target lowered to $12 from $13 at Craig-Hallum
3M ago
Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue
Premium
The Fly
Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue
3M ago
Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
PremiumTipRanks NewswireSurgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
3M ago
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
Premium
TipRanks Newswire
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
4M ago
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
Premium
Company Announcements
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―